New concepts in atopic dermatitis

Liver

Volumn 16, Issue 1, 1996, Pages 144-151

  Boguniewicz, Mark ^a   Leung, Donald Y M ^b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b Children's Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; CORTICOSTEROID; IMMUNOGLOBULIN E;

ATOPIC DERMATITIS; CLINICAL FEATURE; HYDRATION; IMMUNOREGULATION; IMMUNOTHERAPY; INFECTION; PATIENT EDUCATION; PRURITUS; REVIEW;

ANTIGENS; COMBINED MODALITY THERAPY; DERMATITIS, ATOPIC; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOGLOBULIN E; IMMUNOLOGIC MEMORY; PROGNOSIS; T-LYMPHOCYTES;

EID: 3142636906     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Leung DYM, Rhodes AR, Geha RS, Schneider L, Ring J. Atopic dermatitis. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freeberg IM, Austen KF, eds. Dermatology in General Medicine. 4th ed. New York, NY: McGraw-Hill; 1993:1543-1564.
2. Schultz-Larsen F, Holm NV, Henningsen K. Atopic dermatitis: a genetic-epidemiologic study in a population based twin sample. J Am Acad Dermatol. 1986;15:487-494.
3. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatol Venereol (Stockh). 1980;92:44-47.
4. Boguniewicz M, Lenng DYM. Clinical implications of cellular inflammation in atopic dermatitis. Pract Allergy Immunol. 1994;9:94-100.
5. Picker LJ, Butcher EC. Physiological and molecular mechanisms of lymphocyte homing. Ann Rev Immunol. 1992;10:561-591.
6. Van der Heijden F, Wierenga EA, Bos JD, Kapsenberg JL. High frequency of IL-4 producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol. 1991;97:389-394.
7. Leiferman KM, Ackerman SJ, Sampson HA, Haugen HS, Venecie PY, Gleich GJ. Dermal deposition of eosinophil granule major basic protein in atopic dermatitis: comparison with onchocerciasis. N Engl J Med. 1985;313:282-285.
8. Bruijnzeel-Koomen C, van Wichen DF, Toonstra J, Berrens L, Bruijnzeel PLB. The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch Dermatol Res. 1986;278:199-205.
9. Sieling PA, Abrams JS, Yamamura M, et al. Immunosuppressive roles for IL-10 and IL-4 in human infection. J Immunol. 1993;150:5501-5510.
10. Hamid Q, Boguniewicz M, Leung DYM. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest. 1994;94:870-876.
11. Sampson HA, Broadbent K, Bernhisel-Broadbent J. Spontaneous basophil histamine release and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med. 1989;321:228-232.
12. Leung DYM, Harbeck R, Bina P, Hanifin JM, Reiser RF, Sampson HA. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis: evidence for a new group of allergens. J Clin Invest. 1993;92: 1374-1380.
13. Drake LA, Fallon JD, Sober A (Doxepin Study Group). Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. J Am Acad Dermatol. 1994;31: 613-616.
14. Leung DYM, Schneider L, Moody C, Hirsch R, Goldstein G, Hanifin J. Thymopentin therapy reduces the clinical severity of atopic dermatitis. J Allergy Clin Immunol 1990;85:927-934.
15. Boguniewicz M, Jaffe HS, Izu A, et al. Recombinant gamma Interferon in treatment of patients with atopic dermatitis and elevated IgE levels. Am J Med. 1990;88:365-370.
16. Hanifin J, Schneider LC, Leung DYM, et al. Recombinant Interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol. 1993; 28:189-197.
17. Sowden JM, Berth-Jones J, Ross JS, et al. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet. 1991;338:137-140.
18. Nakagawa H, Etoh T, Ishibashi Y, et al. Tacrolimus ointment for atopic dermatitis. Lancet. 1994;344:24.